NGNE · Neurogene Inc.
$37.34
+0.03 (+0.08%)
At close · Jul 20
Market Cap
$590.04M
Shares
15.80M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-03-13 | STUART COBB | Officer | 6,797 | 2026-03-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-27 | Christine Cvijic | Officer | 9,600 | 2026-02-27 | J.P. Morgan Securities LLC |
| 2025-05-14 | STUART COBB | Officer | 6,797 | 2025-05-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-03-07 | MARTIN BABLER | Director | 2,500 | 2024-03-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-03-04 | SEAN SMITH | Officer | 371 | 2024-03-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-02-09 | TODD SIMPSON | Director | 2,500 | 2024-02-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-02-06 | ERIN LAVELLE | Director | 2,500 | 2024-02-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–7 of 7 filings